Activated AKT and YAP signaling have been implicated in the pathogenesis of intrahepatic cholangiocarcinoma (iCCA), but their specific roles in tumor progression and regulation of the tumor microenvironment remain unclear.
Journal of Hepatology published a clinical update in Research Highlights on 04 Mar 2026.
The item focuses on Distinct molecular pathways regulated by activated AKT and YAP signaling during intrahepatic cholangiocarcinoma progression.
Review the original article for the full source wording and details.